Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Challenging the Conventional Wisdom Around Doxorubicin in Soft Tissue Sarcoma.
Journal: JCO oncology practice
Published: June 12, 2026
Differentiating naturally occurring and disease associated autoantibodies in MPO-ANCA vasculitis through immunogenomic and epitope comparisons.
Journal: Frontiers in medicine
Published: January 09, 2026
High-avidity cathepsin-G-specific CAR T cells for the treatment of acute myeloid leukemia.
Journal: Blood
Published: July 09, 2025
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.
Journal: Blood
Published: July 09, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Journal: Nature
Published: February 27, 2025
Molecular glue degrader function of SPOP inhibitors enhances STING-dependent immunotherapy efficacy in melanoma models.
Journal: The Journal of clinical investigation
Published: January 28, 2025
Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity.
Journal: Nature communications
Published: June 18, 2024
A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD.
Journal: Blood advances
Published: May 16, 2024
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment.
Journal: Immunity
Published: March 12, 2024
4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20.
Journal: Cellular & molecular immunology
Published: November 03, 2023
Last Updated: 09/26/2026